Virtual Visits for Atrial Fibrillation
(PAUSEVirtual Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether virtual visits are as safe as in-person visits for patients with atrial fibrillation (AF) who need to stop taking blood thinners before elective surgery. The goal is to determine if instructions given through phone or video calls can effectively help patients manage their medication without increasing the risk of stroke or bleeding. This approach could offer more convenience and cost savings for patients. Individuals with AF on specific blood thinners, such as warfarin or other direct oral anticoagulants (DOACs), who require planned surgery might be suitable candidates for this trial.
As a Phase 3 trial, this study represents the final step before FDA approval, providing patients an opportunity to contribute to a potentially groundbreaking treatment approach.
Why are researchers excited about this trial?
Researchers are excited about the PAUSE-Virtual trial because it explores a new way of managing anticoagulant use around the time of surgery using virtual visits. Unlike traditional in-person consultations, this method leverages virtual technology to monitor and adjust anticoagulant therapy, potentially offering greater convenience and flexibility for both patients and healthcare providers. This approach could lead to more personalized and timely care, reducing the risk of complications associated with anticoagulant use during surgery. By integrating technology into patient care, this trial aims to enhance patient outcomes and streamline the management process.
Who Is on the Research Team?
James D Douketis, MD
Principal Investigator
McMaster University/St. Joseph's Healthcare
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Virtual Preoperative Management
Participants receive virtual instructions on when to stop and restart anticoagulants and, if needed, how to self-administer heparin bridging
Follow-up
Participants are monitored for safety and effectiveness after the procedure, focusing on stroke/systemic embolism and major bleeding rates
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor